Changes in proinflammatory cytokine activity after menopause

被引:712
作者
Pfeilschifter, J [1 ]
Köditz, R [1 ]
Pfohl, M [1 ]
Schatz, H [1 ]
机构
[1] Univ Bochum, Berufsgenossenschaftliche Kliniken Bergmannsheil, Dept Internal Med, D-44789 Bochum, Germany
关键词
D O I
10.1210/er.23.1.90
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is now a large body of evidence suggesting that the decline in ovarian function with menopause is associated with spontaneous increases in proinflammatory cytokines. The cytokines that have obtained the most attention are IL-1, IL-6, and TNF-alpha. The exact mechanisms by which estrogen interferes with cytokine activity are still incompletely known but may potentially include interactions of the ER with other transcription factors, modulation of nitric oxide activity, antioxidative effects, plasma membrane actions, and changes in immune cell function. Experimental and clinical studies strongly support a link between the increased state of proinflammatory cytokine activity and postmenopausal bone loss. Preliminary evidence suggests that these changes also might be relevant to vascular homeostasis and the development of atherosclerosis. Better knowledge of the mechanisms and the time course of these interactions may open new avenues for the prevention and treatment of some of the most prevalent and important disorders in postmenopausal women.
引用
收藏
页码:90 / 119
页数:30
相关论文
共 509 条
[1]   Cytokines and bone loss in a 5-year longitudinal study - Hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: The Danish Osteoporosis Prevention Study [J].
Abrahamsen, B ;
Bonnevie-Nielsen, V ;
Ebbesen, EN ;
Gram, J ;
Beck-Nielsen, H .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (08) :1545-1554
[2]   Mode of action of interleukin-6 on mature osteoclasts.: Novel interactions with extracellular Ca2+ sensing in the regulation of osteoclastic bone resorption [J].
Adebanjo, OA ;
Moonga, BS ;
Yamate, T ;
Sun, L ;
Minkin, C ;
Abe, E ;
Zaidi, M .
JOURNAL OF CELL BIOLOGY, 1998, 142 (05) :1347-1356
[3]   MECHANICAL-PROPERTIES, BONE-MINERAL CONTENT, AND BONE-COMPOSITION (COLLAGEN, OSTEOCALCIN, IGF-I) OF THE RAT FEMUR - INFLUENCE OF OVARIECTOMY AND NANDROLONE DECANOATE (ANABOLIC-STEROID) TREATMENT [J].
AERSSENS, J ;
VANAUDEKERCKE, R ;
GEUSENS, P ;
SCHOT, LPC ;
OSMAN, AAH ;
DEQUEKER, J .
CALCIFIED TISSUE INTERNATIONAL, 1993, 53 (04) :269-277
[4]   Adipose tissue as an endocrine organ [J].
Ahima, RS ;
Flier, JS .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2000, 11 (08) :327-332
[5]   The induction of cyclooxygenase-2 by 17β-estradiol in endothelial cells is mediated through protein kinase C [J].
Akarasereenont, P ;
Techatraisak, K ;
Thaworn, A ;
Chotewuttakorn, S .
INFLAMMATION RESEARCH, 2000, 49 (09) :460-465
[6]  
AKATSU T, 1991, J BONE MINER RES, V6, P183
[7]   Hormone replacement therapy and urinary prostaglandins in postmenopausal women [J].
Akgül, C ;
Canbaz, M ;
Vural, P ;
Yildirim, A ;
Geren, N .
MATURITAS, 1998, 30 (01) :79-83
[8]   Nuclear factor-κB suppressive and inhibitor-κB stimulatory effects of troglitazone in obese patients with type 2 diabetes:: Evidence of an antiinflammatory action? [J].
Aljada, A ;
Garg, R ;
Ghanim, H ;
Mohanty, P ;
Hamouda, W ;
Assian, E ;
Dandona, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (07) :3250-3256
[9]   Colony-stimulating factor-1 stimulates the fusion process in osteoclasts [J].
Amano, H ;
Yamada, S ;
Felix, R .
JOURNAL OF BONE AND MINERAL RESEARCH, 1998, 13 (05) :846-853
[10]   Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency [J].
Ammann, P ;
Rizzoli, R ;
Bonjour, JP ;
Bourrin, S ;
Meyer, JM ;
Vassalli, P ;
Garcia, I .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) :1699-1703